homeopathic glp 1 RACGP A new study from the

This provides evidence that cardiovascular benefits from GLP-1R agonism may also come from metabolic changes in cardiac tissue through systemic signaling (Almutairi et al

Other insulin-sensitizing treatments can complement these options for a more tailored approach

[DOI] [PMC free article] [PubMed] [Google Scholar] 783.Cegla J., Troke R.C., Jones B., Tharakan G., Kenkre J., McCullough K.A

We conducted a target trial emulation using electronic health records (EHR) from a large multihospital health system to compare the incidence of ED among new users of GLP-1RA with those initiating dipeptidyl peptidase-4 inhibitors (DPP4i)